Trisomy 8 in pediatric acute myeloid leukemia: A NOPHO-AML study-Reference-Cited by-同舟云学术

Trisomy 8 in pediatric acute myeloid leukemia: A NOPHO-AML study

Published:2016-06-23 Issue:9 Volume:55 Page:719-726
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Laursen Anne Cathrine Lund¹^ORCID,Sandahl Julie Damgaard¹,Kjeldsen Eigil²,Abrahamsson Jonas³,Asdahl Peter¹,Ha Shau-Yin⁴,Heldrup Jesper⁵,Jahnukainen Kirsi⁶,Jónsson Ólafur G.⁷,Lausen Birgitte⁸,Palle Josefine⁹,Zeller Bernward¹⁰,Forestier Erik¹¹,Hasle Henrik¹

Affiliation:

1. Department of Pediatrics; Aarhus University Hospital; Aarhus Denmark

2. Cancer Cytogenetics Laboratory; Department of Hematology, Aarhus University Hospital; Aarhus Denmark

3. Institution for Clinical Sciences; Department of Pediatrics, Queen Silvia Children's Hospital; Gothenburg Sweden

4. Department of Pediatrics; Queen Mary Hospital and Hong Kong Pediatric Hematology & Oncology Study Group (HKPHOSG); Hong Kong China

5. Department of Pediatrics; University Hospital; Lund Sweden

6. Children's Hospital, Helsinki University Central Hospital, University of Helsinki; Helsinki Finland

7. Department of Pediatrics; Landspitalinn Reykjavik Iceland

8. Department of Pediatrics and Adolescent Medicine; Rigshospitalet, University of Copenhagen; Copenhagen Denmark

9. Department of Woman's and Children's Health; Uppsala University; Uppsala Sweden

10. Department of Pediatric Medicine; Oslo University Hospital; Oslo Norway

11. Department of Medical Biosciences; Clinical Genetics, Umeå University Hospital; Umeå Sweden

Funder

The Danish Childhood Cancer Foundation

Swedish Childhood Cancer Foundation

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference35 articles.

1. Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate;Abrahamsson;J Clin Oncol,2011

2. AML with gain of chromosome 8 as the sole chromosomal abnormality (+8 sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patients;Alpermann;Leukemia Res,2015

3. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: Results of an international retrospective study;Balgobind;Blood,2009

4. The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia;Balgobind;Leukemia,2011

5. The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG);Betts;Eur J Haematol,2007

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Childhood Acute Myeloid Leukemia: Diagnosis and Novel Treatment;Pharmaceuticals;2023-11-15

2. UBTF ‐internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemia;Genes, Chromosomes and Cancer;2022-12-07

3. Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution;Experimental Hematology & Oncology;2022-09-27

4. Molecular genetic and clinical characterization of acute myeloid leukemia with trisomy 8 as the sole chromosome abnormality;Hematology;2022-05-12

5. Straight to the Point—The Novel Strategies to Cure Pediatric AML;International Journal of Molecular Sciences;2022-02-10